Hypercalcemia as a cause of arterial hypertension in young adults. Clinical casе
Ukrainian Therapeutical Journal · 30.06.2026 · (2) · 54-59
DOI: 10.30978/utj2026-2-54 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ukrainian Therapeutical Journal, online erschienen am 30.06.2026. Verfasst von O. S. Dolia und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Abstract (Originalsprache)
The article presents a clinical course of manifest hypercalcemia in a 28-year-old female patient, which for nine years was verified as symptomatic malignant arterial hypertension. The first manifestations of the disease were recorded in the late stages of pregnancy (36th week), when a sudden rise in blood pressure to 180/100 mm Hg was interpreted as severe preeclampsia, which became an indication for urgent cesarean section. For a long time, arterial hypertension was resistant to combined antihypertensive therapy, accompanied by cephalgia and recurrent nephrolithiasis of the left kidney, which required lithotripsy and stenting. Given the young age of the patient and the malignant course of the disease, a sequential extended search for secondary causes of hypertension was conducted. After excluding the most common pathologies (pheochromocytoma, hypercorticism, renovascular hypertension), a comprehensive examination revealed persistent hypercalcemia as a manifestation of primary hyperparathyroidism. Surgical intervention was performed—left lower parathyroidectomy. This provided rapid normalization of parathyroid hormone and restoration of phosphorus-calcium metabolism. However, according to 24-hour blood pressure monitoring, complete normalization of blood pressure was achieved only in the late postoperative period (after 5 months), which confirms the delayed nature of vascular recovery after the elimination of chronic hypercalcemia. This case demonstrates that primary hyperparathyroidism should be considered as an important cause of secondary arterial hypertension in young patients. Including screening for calcium and parathyroid hormone levels in examination protocols for resistant hypertension is critically important for early diagnosis and prevention of irreversible cardiovascular complications.
Zitieren
APA
Dolia, O. S., & Sviatun, D. V. (2026). Hypercalcemia as a cause of arterial hypertension in young adults. Clinical casе. Ukrainian Therapeutical Journal, 54-59. https://doi.org/10.30978/utj2026-2-54
Vancouver
Dolia OS, Sviatun DV. Hypercalcemia as a cause of arterial hypertension in young adults. Clinical casе. Ukrainian Therapeutical Journal. 2026:54-59. doi:10.30978/utj2026-2-54
BibTeX
@article{Dolia2026,
author = {Dolia, O. S. and Sviatun, D. V.},
title = {Hypercalcemia as a cause of arterial hypertension in young adults. Clinical casе},
journal = {Ukrainian Therapeutical Journal},
year = {2026},
number = {2},
pages = {54--59},
doi = {10.30978/utj2026-2-54}
}
EUVIMED